Activation of early signaling transcription factor, NF-kappaB following low-level manganese exposure.
Occupational and environmental exposure to manganese (Mn(2+)) is an increasing problem. It manifests neuronal degeneration characterized by dyskinesia resembling Parkinson's disease. The study was performed to test the hypotheses whether exposure to Mn(2+) alters cellular physiology and promotes intracellular signaling mechanism in dopaminergic neuronal cell line. Since transcription factors have been shown to play an essential role in the control of cellular proliferation and survival, catecholaminergic rich pheochromocytoma (PC12) cells were used to measure changes in the DNA binding activities of nuclear factor kappa B (NF-kappaB) by electrophoretic mobility shift assay (EMSA) following Mn(2+) (0.1-10 microM) exposure. Cells that were exposed to Mn(2+) produced five-fold-activation of transcription factor NF-kappaB DNA binding activity. This remarkable increase was seen within 30-60 min period of Mn(2+) exposure. Activation of NF-kappaB DNA binding activity by Mn(2+) at 1.0 microM correlated with proteolytic degradation of the inhibitory subunit IkappaB(alpha) as evidenced in cytosol. Additional experiments on NF-kappaB reporter gene assay also showed increased NF-kappaB gene expression at 1.0 and 5.0 microM Mn(2+) and this was completely blocked in the presence of NF-kappaB translocation inhibitor, IkappaB(alpha)-DN supporting that NF-kappaB induction occurred during Mn(2+) exposure. In addition, Mn(2+) exposure to PC 12 cells led to activation of signal responsive mitogen activated protein kinase kinase (MAPKK). These results suggest that Mn(2+) at a low dose appears to induce the expression of immediate early gene, NF-kappaB through MAPKK by a mechanism in which IkappaB(alpha) phosphorylation may be involved.
Ramesh
Govindarajan T
GT
Molecular Neurotoxicology Laboratory, Department of Biology, College of Science and Technology, Texas Southern University, Houston, TX 77004, USA.
Ghosh
Debabrata
D
Gunasekar
Palur G
PG
D000818:Animals; D004247:DNA / Q000235:genetics / Q000378:metabolism; D024202:Electrophoretic Mobility Shift Assay; D004789:Enzyme Activation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D017930:Genes, Reporter / Q000235:genetics; D020672:I-kappa B Proteins / Q000378:metabolism; D008345:Manganese / Q000008:administration & dosage* / Q000494:pharmacology*; D020929:Mitogen-Activated Protein Kinase Kinases / Q000378:metabolism; D000072000:NF-KappaB Inhibitor alpha; D016328:NF-kappa B / Q000378:metabolism*; D016716:PC12 Cells; D011485:Protein Binding / Q000187:drug effects; D051381:Rats; D015398:Signal Transduction / Q000187:drug effects*; D013997:Time Factors
D020672:I-kappa B Proteins; D016328:NF-kappa B; C000606206:Nfkbia protein, rat; D000072000:NF-KappaB Inhibitor alpha; D008345:Manganese; D004247:DNA; D020929:Mitogen-Activated Protein Kinase Kinases